Related Experiment Video
Updated: Jun 12, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Do statins beneficially or adversely affect glucose homeostasis?
Michael S Kostapanos1, George L Liamis, Haralampos J Milionis
1Department of Internal Medicine, School of Medicine, University of Ioannina, 45110 Ioannina, Greece. egepi@cc.uoi.gr
Current Vascular Pharmacology
|May 29, 2010
Summary
Statin use impacts glucose metabolism, with some statins potentially increasing diabetes risk. Pravastatin may benefit glucose control, while more research is needed for others.
Area of Science:
- Cardiovascular Pharmacology
- Endocrinology
- Metabolic Syndrome
Background:
- Statin therapy is widely used for cardiovascular disease prevention, including in patients with prediabetes or diabetes.
- The impact of statins on glucose metabolism and diabetes risk is controversial and requires clarification.
- Understanding these effects is crucial for optimizing cardiovascular and metabolic health management.
Purpose of the Study:
- To review the effects of different statins on glucose homeostasis and diabetes risk.
- To explore the mechanisms underlying statin-induced alterations in carbohydrate metabolism.
- To identify statins that may be preferentially used for improving glycemic control.
Main Methods:
- Systematic review of experimental and clinical trial data on statin effects on glycemic outcomes.
- Analysis of studies investigating the mechanisms of statin action on carbohydrate metabolism.
- Comparison of different statin agents regarding their impact on glucose homeostasis.
Main Results:
- Statin lipophilicity and HMG-CoA reductase inhibition are linked to adverse effects on carbohydrate metabolism.
- Beneficial effects may stem from hypotriglyceridemic capacity, improved pancreatic blood flow, anti-inflammatory properties, and adipokine modulation.
- Pravastatin appears to favorably impact glucose metabolism and reduce diabetes risk; effects of other statins (rosuvastatin, atorvastatin, simvastatin) are controversial, and data on lovastatin, fluvastatin, and pitavastatin are limited.
Conclusions:
- Statin treatment has variable effects on glucose metabolism, with potential risks and benefits depending on the specific agent.
- Hydrophilic statins (pravastatin, rosuvastatin, pitavastatin) may offer preferable glycemic outcomes compared to lipophilic statins (atorvastatin, simvastatin).
- Further comparative trials are necessary to definitively establish the role of various statins in managing glucose homeostasis and diabetes risk.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Acarbose and miglitol are typically...
01:02Glucose Homeostasis: Regulation of Blood Glucose
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
01:23Dipeptidyl Peptidase 4 Inhibitors
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
01:16Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...